NCT01332500View on ClinicalTrials.gov

Treximet ™ Pharmacy Budget Impact Model Database Validation Study

CompletedOBSERVATIONAL
Enrollment

61,737

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Migraine Disorders
Interventions
DRUG

Sumatriptan/Naproxen combination

Sumatriptan and Naproxen Sodium

DRUG

other oral triptans

almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01332500 - Treximet ™ Pharmacy Budget Impact Model Database Validation Study | Biotech Hunter | Biotech Hunter